287 related articles for article (PubMed ID: 22617813)
21. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
[TBL] [Abstract][Full Text] [Related]
22. Radiological diagnosis of small pulmonary nodules detected on low-dose screening computed tomography.
Tsushima K; Sone S; Hanaoka T; Kubo K
Respirology; 2008 Nov; 13(6):817-24. PubMed ID: 18811880
[TBL] [Abstract][Full Text] [Related]
23. Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.
Raymakers AJN; Mayo J; Lam S; FitzGerald JM; Whitehurst DGT; Lynd LD
Appl Health Econ Health Policy; 2016 Aug; 14(4):409-418. PubMed ID: 26873091
[TBL] [Abstract][Full Text] [Related]
24. Lung cancer screening with MRI: results of the first screening round.
Meier-Schroers M; Homsi R; Skowasch D; Buermann J; Zipfel M; Schild HH; Thomas D
J Cancer Res Clin Oncol; 2018 Jan; 144(1):117-125. PubMed ID: 28932985
[TBL] [Abstract][Full Text] [Related]
25. The role of computer-assisted radiographer reporting in lung cancer screening programmes.
Hall H; Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Batty J; Woznitza N; Ahmed A; Burke S; Shaw P; Soo MJ; Taylor M; Navani N; Bhowmik A; Baldwin DR; Duffy SW; Devaraj A; Nair A; Janes SM
Eur Radiol; 2022 Oct; 32(10):6891-6899. PubMed ID: 35567604
[TBL] [Abstract][Full Text] [Related]
26. A National Survey of Pulmonologists' Views on Low-Dose Computed Tomography Screening for Lung Cancer.
Iaccarino JM; Clark J; Bolton R; Kinsinger L; Kelley M; Slatore CG; Au DH; Wiener RS
Ann Am Thorac Soc; 2015 Nov; 12(11):1667-75. PubMed ID: 26368003
[TBL] [Abstract][Full Text] [Related]
27. Subcentimeter lung nodules stable for 2 years at LDCT: long-term follow-up using volumetry.
Shin KE; Lee KS; Yi CA; Chung MJ; Shin MH; Choi YH
Respirology; 2014 Aug; 19(6):921-8. PubMed ID: 24934105
[TBL] [Abstract][Full Text] [Related]
28. Effective use of low-dose computed tomography lung cancer screening.
Jeffers CD; Pandey T; Jambhekar K; Meek M
Curr Probl Diagn Radiol; 2013; 42(5):220-30. PubMed ID: 24070715
[TBL] [Abstract][Full Text] [Related]
29. Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening.
Kim YW; Kwon BS; Lim SY; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Chung JH; Ji E; Lee CT
Thorax; 2021 Oct; 76(10):980-988. PubMed ID: 33859050
[TBL] [Abstract][Full Text] [Related]
30. Low-Dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center.
Lewis JA; Petty WJ; Tooze JA; Miller DP; Chiles C; Miller AA; Bellinger C; Weaver KE
Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):664-70. PubMed ID: 25613118
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.
Raghu VK; Zhao W; Pu J; Leader JK; Wang R; Herman J; Yuan JM; Benos PV; Wilson DO
Thorax; 2019 Jul; 74(7):643-649. PubMed ID: 30862725
[TBL] [Abstract][Full Text] [Related]
32. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
Fasola G; Belvedere O; Aita M; Zanin T; Follador A; Cassetti P; Meduri S; De Pangher V; Pignata G; Rosolen V; Barbone F; Grossi F
Oncologist; 2007 Oct; 12(10):1215-24. PubMed ID: 17962615
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of inhaled budesonide on screening-detected lung nodules.
Veronesi G; Lazzeroni M; Szabo E; Brown PH; DeCensi A; Guerrieri-Gonzaga A; Bellomi M; Radice D; Grimaldi MC; Spaggiari L; Bonanni B
Ann Oncol; 2015 May; 26(5):1025-1030. PubMed ID: 25672894
[TBL] [Abstract][Full Text] [Related]
34. Queensland Lung Cancer Screening Study: rationale, design and methods.
Marshall HM; Bowman RV; Crossin J; Lau MA; Slaughter RE; Passmore LH; McCaul EM; Courtney DA; Windsor MN; Yang IA; Smith IR; Keir BJ; Hayes TJ; Redmond SJ; Zimmerman PV; Fong KM
Intern Med J; 2013 Feb; 43(2):174-82. PubMed ID: 22471951
[TBL] [Abstract][Full Text] [Related]
35. Screening for lung cancer.
Midthun DE
Clin Chest Med; 2011 Dec; 32(4):659-68. PubMed ID: 22054878
[TBL] [Abstract][Full Text] [Related]
36. Implementing lung cancer screening: the US experience.
Aberle DR
Clin Radiol; 2017 May; 72(5):401-406. PubMed ID: 28069160
[TBL] [Abstract][Full Text] [Related]
37. [Screening for lung cancer using CT: time for implementation?].
de Jong PA; Lammers JW
Ned Tijdschr Geneeskd; 2013; 157(46):A7019. PubMed ID: 24220184
[TBL] [Abstract][Full Text] [Related]
38. Initial Outcomes of a Lung Cancer Screening Program in an Integrated Community Health System.
Miller AT; Kruger P; Conner K; Robertson T; Rowley B; Sause W; Ruckdeschel JC; Blagev DP
J Am Coll Radiol; 2016 Jun; 13(6):733-7. PubMed ID: 27131618
[TBL] [Abstract][Full Text] [Related]
39. Early Lung Cancer Action Project: overall design and findings from baseline screening.
Henschke CI; McCauley DI; Yankelevitz DF; Naidich DP; McGuinness G; Miettinen OS; Libby DM; Pasmantier MW; Koizumi J; Altorki NK; Smith JP
Lancet; 1999 Jul; 354(9173):99-105. PubMed ID: 10408484
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience.
Shmueli A; Fraifeld S; Peretz T; Gutfeld O; Gips M; Sosna J; Shaham D
Value Health; 2013; 16(6):922-31. PubMed ID: 24041342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
